Prometheus | Protein Stability + Aggregation + Particle Sizing

  • Prometheus Panta: The new gold standard for biologics characterization1:41

    Prometheus Panta: The new gold standard for biologics characterization

    Choosing the right stability characterization tool for your biologics research is a big commitment. You’re going to be screening and optimizing lots of candidates, and you’ll need data on thermal stab

    Watch
  • How early discovery and development teams use Dynamic Light Scattering to de⁠-⁠risk downstream biologics development

    How early discovery and development teams use Dynamic Light Scattering to de⁠-⁠risk downstream biologics development

    As a discovery or early development scientist, you’re tasked with identifying the most promising biologics candidates. Your hard work during early development enables straightforward and efficient...

    Read
  • Four integrated technologies for Biologics developability assessment4:51

    Four integrated technologies for Biologics developability assessment

    The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics

    Watch
  • The biologics researcher's guide to DLS

    The biologics researcher's guide to DLS

    Read
  • Top 8 biologics conferences of 2023 at a glance

    Top 8 biologics conferences of 2023 at a glance

    Use this downloadable list of 2023 biologics conferences to select which one to attend. Learn when and where they’ll happen, who’ll be there, and the main focus.

    Read
  • Ready to tackle your challenging stability characterizations?

    Discover tools
  • DLS easily explained: What it tells you about your protein34:16

    DLS easily explained: What it tells you about your protein

    Join this webinar to learn about the physical phenomenon that drives Dynamic Light Scattering (DLS), and see a few examples of how DLS gives you deeper insights.

    Watch
  • How 2bind identifies the best buffer for a vaccine antigen target with Prometheus Panta2:34

    How 2bind identifies the best buffer for a vaccine antigen target with Prometheus Panta

    Discover how 2bind applied multi-parameter characterization from a single experiment to find the optimal buffer for a vaccine antigen target.

    Watch
  • Biologics developability: learn how Merck uses Prometheus Panta to create developability profiles for their mAbs

    Biologics developability: learn how Merck uses Prometheus Panta to create developability profiles for their mAbs

    Read
  • Select the best biologics candidates with high-quality, multi-parameter stability characterization

    Select the best biologics candidates with high-quality, multi-parameter stability characterization

    Read
  • How Janssen optimizes the stability of a therapeutic mAb1:31

    How Janssen optimizes the stability of a therapeutic mAb

    Discover how Janssen improved the stability of a promising prostate cancer targeting mAb. You’ll learn why it is important to optimize stability measurements of a therapeutic mAb.

    Watch
  • Use stability profiling to build more effective gene therapy vectors with Prometheus Panta

    Use stability profiling to build more effective gene therapy vectors with Prometheus Panta

    Read
  • NanoTemper Technologies arms gene therapy scientists with Static Light Scattering to sharpen their tool kit for development of AAVs

    NanoTemper Technologies arms gene therapy scientists with Static Light Scattering to sharpen their tool kit for development of AAVs

    SOUTH SAN FRANCISCO, Calif Feb 16 2022 — NanoTemper Technologies today announced the addition of Static Light Scattering (SLS) to their wildly successful Prometheus Panta, turning their instrument...

    Read
  • Serotyping: why, when, and how to assess your AAV therapeutic to get it approved14:07

    Serotyping: why, when, and how to assess your AAV therapeutic to get it approved

    When you develop an AAV therapeutic, you need to assess many key parameters, or Critical Quality Attributes (CQAs), in order to track progress and, ultimately, get your therapeutic approved. As part

    Watch
  • Ways light scattering technologies help you if you’re in gene therapy

    Ways light scattering technologies help you if you’re in gene therapy

    Read
  • 8 biologics conferences you won’t want to miss in 2023

    8 biologics conferences you won’t want to miss in 2023

    When you’re part of an industry that moves quickly, it’s important to keep up. You hear about biotherapeutics approvals, and big pharma news, but nothing matches the biologics conference experience.

    Read
  • Learn the pros and cons of these 3 methods to serotype your AAV gene therapy vectors

    Learn the pros and cons of these 3 methods to serotype your AAV gene therapy vectors

    Read
  • 5 benefits of optimizing your formulation buffer to get your AAV therapeutic approved

    5 benefits of optimizing your formulation buffer to get your AAV therapeutic approved

    As a gene therapy scientist, you face an abundance of challenges when working to build an effective AAV therapeutic. Many steps of the development workflow have yet to be standardized and the...

    Read
  • Four technologies to profile your AAVs

    Four technologies to profile your AAVs

    Read
  • How Merck KGaA uses light scattering measurements for better developability assessment of biologic therapeutics

    How Merck KGaA uses light scattering measurements for better developability assessment of biologic therapeutics

    Read
  • How stability studies get your mAb candidate FDA-approved

    How stability studies get your mAb candidate FDA-approved

    Read
  • loading
    Loading more...